Cancer Risk Great in Crohn's Disease Patients Treated with Combination Drug Therapy - IBD News - Cancer
John Kisiel, M.D., a gastroenterologist at Mayo Clinic, discusses a recently published article in Gastroenterology about the combination therapy of adalimumab and immunomodulators and the risk for nonmelanoma skin cancer and other cancers in patients with Crohn’s disease.